Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study

被引：0
|
作者：
Constant V. M. Verschuur
S. R. Suwijn
B. Post
M. Dijkgraaf
B. R. Bloem
J. J. van Hilten
T. van Laar
G. Tissingh
G. Deuschl
A. E. Lang
R. J. de Haan
R. M. A. de Bie
机构：
[1] University of Amsterdam,Department of Neurology, Academic Medical Center
[2] Radboud University Medical Center,Department of Neurology, Donders Institute for Brain, Cognition and Behavior
[3] Clinical Research Unit,Academic Medical Center
[4] Leiden University Medical Center,Department of Neurology
[5] University Medical Center Groningen,Department of Neurology
[6] Atrium-Orbis Medical Center Heerlen/Sittard,Department of Neurology
[7] University Medical Center Schleswig-Holstein,Department of Neurology
[8] University of Toronto,The Edmond J. Safra Program in Parkinson’s Disease and Morton and Gloria Shulman Movement Disorders Center, Toronto Western Hospital
来源：
BMC Neurology | / 15卷
关键词：
Parkinson’s disease; Levodopa; Randomised delayed-start placebo-controlled trial; Disease modifying;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study
    Verschuur, Constant V. M.
    Suwijn, S. R.
    Post, B.
    Dijkgraaf, M.
    Bloem, B. R.
    van Hilten, J. J.
    van Laar, T.
    Tissingh, G.
    Deuschl, G.
    Lang, A. E.
    de Haan, R. J.
    de Bie, R. M. A.
    BMC NEUROLOGY, 2015, 15
  • [2] Rasagiline in Chinese Patients with Early-stage Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled, Delayed-start Trial
    Su, W.
    Liu, H. J.
    Wang, L. J.
    Ye, Q. Y.
    Cao, L.
    Zhou, H. Y.
    Luo, X. G.
    Ding, Z. T.
    Wang, T.
    Wang, Q.
    Ma, H. Z.
    Xu, E. H.
    Chen, H. B.
    MOVEMENT DISORDERS, 2023, 38 : S52 - S53
  • [3] A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
    Olanow, C. Warren
    Rascol, Olivier
    Hauser, Robert
    Feigin, Paul D.
    Jankovic, Joseph
    Lang, Anthony
    Langston, William
    Melamed, Eldad
    Poewe, Werner
    Stocchi, Fabrizio
    Tolosa, Eduardo
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13): : 1268 - 1278
  • [4] A multi-centre, placebo-controlled, double-blind trial to examine the safety and efficacy of pimavanserin in the treatment of psychosis in Parkinson's disease
    Friedman, J. H.
    Ravina, B.
    Mills, R.
    Williams, H.
    Revell, S.
    Bahr, D.
    Tison, F.
    Burn, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 656 - 656
  • [5] Synbiotics in patients at risk for spontaneous preterm birth: protocol for a multi-centre, double-blind, randomised placebo-controlled trial (PRIORI)
    Nulens, Katrien
    Papy, Els
    Tartaglia, Katrien
    Dehaene, Isabelle
    Logghe, Hilde
    Van Keirsbilck, Joachim
    Chantraine, Frederic
    Masson, Veronique
    Simoens, Eva
    Gysemans, Willem
    Bruckers, Liesbeth
    Lebeer, Sarah
    Allonsius, Camille Nina
    Oerlemans, Eline
    Steensels, Deborah
    Reynders, Marijke
    Timmerman, Dirk
    Devlieger, Roland
    Van Holsbeke, Caroline
    TRIALS, 2024, 25 (01)
  • [6] Decreasing risk of psychosis by sulforaphane study protocol for a randomized, double-blind, placebo-controlled, clinical multi-centre trial
    Li, Zhixing
    Zhang, Tianhong
    Xu, Lihua
    Wei, Yanyan
    Tang, Yingying
    Hu, Qiang
    Liu, Xiaohua
    Li, Xiaolong
    Davis, John
    Smith, Robert
    Jin, Hua
    Wang, Jijun
    EARLY INTERVENTION IN PSYCHIATRY, 2021, 15 (03) : 585 - 594
  • [7] Fibrosing Alveolitis in scleroderma trial (FAST) - A multi-centre prospective randomised double-blind placebo-controlled trial.
    Hoyles, RK
    Ellis, RW
    Herrick, AL
    McHugh, NJ
    Foley, NM
    Pearson, SB
    Emery, P
    Veale, DJ
    Denton, CP
    Wells, AU
    Black, CM
    du Bois, RM
    ARTHRITIS AND RHEUMATISM, 2005, 52 (12): : 4110 - 4110
  • [8] Antidyskinetic effects of levetiracetam on levodopa-induced dyskinesias in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    Loehle, M.
    Wolz, M.
    Strecker, K.
    Schneider, C.
    Schwanebeck, U.
    Reichmann, H.
    Graehlert, X.
    Schwarz, J.
    Storch, A.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S116 - S117
  • [9] A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study)
    Hegerl, Ulrich
    Mergl, Roland
    Sander, Christian
    Dietzel, Jens
    Bitter, Istvan
    Demyttenaere, Koen
    Gusmao, Ricardo
    Gonzalez-Pinto Arrillaga, Ana
    Zorrilla, Inaki
    Garcia Alocen, Adriana
    Perez Sola, Victor
    Vieta, Eduard
    Juckel, Georg
    Zimmermann, Ulrich S.
    Bauer, Michael
    Sienaert, Pascal
    Quintao, Sonia
    Edel, Marc-Andreas
    Bolyos, Csilla
    Ayuso-Mateos, Jose Luis
    Lopez-Garcia, Pilar
    Kluge, Michael
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 (01) : 185 - 194
  • [10] OCEAN Study in Parkinson's Disease: Status Update of a Randomised Double-Blind Placebo-Controlled Trial of Opicapone
    Chaudhuri, K.
    Odin, P.
    Ferreira, J.
    Antonini, A.
    Rascol, O.
    Kurtis, M.
    Storch, A.
    Bannister, K.
    Costa, R.
    Magalhaes, D.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2022, 37 : S321 - S322
12345